Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis

S. Ashique, N. Mishra, A. Garg, BZ. Sibuh, P. Taneja, G. Rai, S. Djearamane, LS. Wong, N. Al-Dayan, S. Roychoudhury, KK. Kesari, P. Slama, S. Roychoudhury, PK. Gupta

. 2023 ; 10 (-) : 1126579. [pub] 20230720

Status not-indexed Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc23015681

Ulcerative colitis (UC) is presently considered a multifactorial pathology, which may lead to persistent inflammatory action of the gastrointestinal tract (GIT) because of an improperly managed immunological reactivity to the intestinal microbiota found in the GIT. The immune response to common commensal microbes plays an essential role in intestinal inflammation related to UC synbiotics, and it is an important element in the optimal therapy of UC. Therefore, synbiotics, i.e., a mixture of prebiotics and probiotics, may help control the diseased state. Synbiotics alleviate the inflammation of the colon by lowering the reactive oxygen species (ROS) and improving the level of antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPX), and superoxide dismutase (SOD). Prebiotic supplementation is not a common practice at the moment, despite numerous research findings proving that the benefits of both probiotics and prebiotics encourage their continued existence and positioning in the GIT, with positive effects on human health by managing the inflammatory response. However, the fact that there have been fewer studies on the treatment of UC with different probiotics coupled with selected prebiotics, i.e., synbiotics, and the outcomes of these studies have been very favorable. This evidence-based study explores the possible role of ROS, SOD, and synbiotics in managing the UC. The proposed review also focuses on the role of alteration of gut microbiota, antioxidant defense in the gastrointestinal tract, and the management of UC. Thus, the current article emphasizes oxidative stress signaling in the GI tract, oxidative stress-based pathomechanisms in UC patients, and UC therapies inhibiting oxidative stress' effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015681
003      
CZ-PrNML
005      
20250819151505.0
007      
ta
008      
231010e20230720sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnut.2023.1126579 $2 doi
035    __
$a (PubMed)37545572
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ashique, Sumel $u Department of Pharmaceutics, Pandaveswar School of Pharmacy, Pandaveswar, West Bengal, India
245    10
$a Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis / $c S. Ashique, N. Mishra, A. Garg, BZ. Sibuh, P. Taneja, G. Rai, S. Djearamane, LS. Wong, N. Al-Dayan, S. Roychoudhury, KK. Kesari, P. Slama, S. Roychoudhury, PK. Gupta
520    9_
$a Ulcerative colitis (UC) is presently considered a multifactorial pathology, which may lead to persistent inflammatory action of the gastrointestinal tract (GIT) because of an improperly managed immunological reactivity to the intestinal microbiota found in the GIT. The immune response to common commensal microbes plays an essential role in intestinal inflammation related to UC synbiotics, and it is an important element in the optimal therapy of UC. Therefore, synbiotics, i.e., a mixture of prebiotics and probiotics, may help control the diseased state. Synbiotics alleviate the inflammation of the colon by lowering the reactive oxygen species (ROS) and improving the level of antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPX), and superoxide dismutase (SOD). Prebiotic supplementation is not a common practice at the moment, despite numerous research findings proving that the benefits of both probiotics and prebiotics encourage their continued existence and positioning in the GIT, with positive effects on human health by managing the inflammatory response. However, the fact that there have been fewer studies on the treatment of UC with different probiotics coupled with selected prebiotics, i.e., synbiotics, and the outcomes of these studies have been very favorable. This evidence-based study explores the possible role of ROS, SOD, and synbiotics in managing the UC. The proposed review also focuses on the role of alteration of gut microbiota, antioxidant defense in the gastrointestinal tract, and the management of UC. Thus, the current article emphasizes oxidative stress signaling in the GI tract, oxidative stress-based pathomechanisms in UC patients, and UC therapies inhibiting oxidative stress' effects.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mishra, Neeraj $u Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India
700    1_
$a Garg, Ashish $u Department of P.G. Studies and Research in Chemistry and Pharmacy, Rani Durgavati University, Jabalpur, India
700    1_
$a Sibuh, Belay Zeleke $u Department of Biotechnology, Sharda School of Engineering and Technology, Sharda University, Greater Noida, India
700    1_
$a Taneja, Pankaj $u Department of Biotechnology, Sharda School of Engineering and Technology, Sharda University, Greater Noida, India
700    1_
$a Rai, Gopal $u Department of Pharmaceutics, Guru Ramdas Institute of Science and Technology, Jabalpur, India
700    1_
$a Djearamane, Sinouvassane $u Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, Malaysia
700    1_
$a Wong, Ling Shing $u Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia
700    1_
$a Al-Dayan, Noura $u Department of Medical Lab Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia
700    1_
$a Roychoudhury, Shatabhisha $u Health Centre, Assam University, Silchar, India
700    1_
$a Kesari, Kavindra Kumar $u Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia $u Department of Applied Physics, Aalto University, Espoo, Finland
700    1_
$a Slama, Petr $u Laboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia
700    1_
$a Roychoudhury, Shubhadeep $u Department of Life Science and Bioinformatics, Assam University, Silchar, India $7 xx0334841
700    1_
$a Gupta, Piyush Kumar $u Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia $u Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, India $u Department of Biotechnology, Graphic Era Deemed to be University, Dehradun, India
773    0_
$w MED00200569 $t Frontiers in nutrition $x 2296-861X $g Roč. 10 (20230720), s. 1126579
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37545572 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20250819151447 $b ABA008
999    __
$a ok $b bmc $g 1997224 $s 1202043
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 10 $c - $d 1126579 $e 20230720 $i 2296-861X $m Frontiers in nutrition $n Front Nutr $x MED00200569
LZP    __
$a Pubmed-20231010

Find record

Citation metrics

Archiving options